WayneBBatchelorMDMHS,MBA,FACC,FSCAI(He/Him)

Interventional Cardiology, Vascular Medicine

President, Medicine Service Line Inova Health System Fairfax, Virginia, USA. Professor of Medicine Duke University School of Medicine

Join to view full profile

Dr. Batchelor is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Batchelor's full profile

Already have an account?

Office
8081 Innovation Park Dr
700
Fairfax, VA 22031
Phone+1 571-472-2900

Fax+1 571-472-2901

Summary

Dr. Wayne Batchelor is an Interventional Cardiologist and President of the Medicine Service Line at the Inova Health System in Fairfax, Virginia, U.S.A. He is also a Professor of Medicine at Duke University, Chair of the American College of Cardiology's (ACC) Interventional Cardiology Sectional Leadership Council, and Vice-Chair of the NCDR STS/ACC TVT Registry. He has decades of experience as an interventional cardiologist, physician executive, physician scientist, and educator. He has previously served as system Director of Interventional Cardiology and Interventional Research and Associate Director of Inova Schar Heart and Vascular, President of Southern Medical Group, P.A., in Tallahassee Florida, Chair of the Tallahassee Memorial Hospital (TMH) Medical Staff Executive Committee, and on the TMH Board of Directors. Dr. Batchelor has special expertise in the treatment of acute myocardial infarction complicated by cardiogenic shock, complex/high risk percutaneous coronary intervention (PCI), structural heart disease, clinical trials in cardiovascular disease, regulatory science and health care disparities. He has lectured extensively, both nationally and internationally, published over 250 peer-reviewed original abstracts/manuscripts, multiple book chapters and participated in over 175 clinical trials, including serving as National Principal Investigator and numerous Clinical Trial Steering Committees. He is a Senior Advisor for the Journal of the American College of Cardiology (JACC) and serves on the Editorial Boards of Circulation, Journal of the Society of Coronary Angiography and Intervention (JSCAI), and Cardiovascular Revascularization Medicine (CRM). Dr. Batchelor recently received an Executive MBA from the NYU Stern School of Business in 2024 and is a special government employee/consultant to the U.S. Food and Drug Administration (FDA) in the Cardiovascular Devices Branch.

Education & Training

NYU Stern School of BusinessExecutive MBA, 2022 - 2024
Duke UniversityMasters of Health Science, 1998 - 1999
Duke University HospitalFellowship, Cardiovascular Disease, 1996 - 1999
University of TorontoCardiology Fellowship, 1994 - 1996
University of TorontoInternal Medicine, 1991 - 1994
Queen's University at KingstonClass of 1990

Certifications & Licensure

VA State Medical License 2019 - 2026
FL State Medical License 2002 - 2020
GA State Medical License 2005 - 2019
NC State Medical License 1996 - 1999
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

Physician of the Year Capital Medical Society, 2017
CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013
Fellow (FACC) American College of Cardiology

Clinical Trials

A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System Start of enrollment: 2012 Dec 01
Terminated
Phase 3
Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) and COAPT CAS Start of enrollment: 2012 Aug 01
Active, not recruiting
Not Applicable
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN Start of enrollment: 2013 Dec 01
Completed
Not Applicable
PLATINUM Diversity Start of enrollment: 2014 Oct 01
Completed
ABSORB Post-Approval Clinical Study Start of enrollment: 2017 Aug 01
Withdrawn
Not Applicable
WATCH-TAVR, WATCHMAN for Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement Start of enrollment: 2017 Dec 15
Completed
Not Applicable
Ultrasound Comparison of Radial Artery Hyperplasia After Use of a 7F Sheathless Guide vs. 6F Sheath/Guide Combination Start of enrollment: 2016 Feb 25
Completed
Not Applicable
Effects of Passive Muscle Stretching on Vascular Function and Symptoms of PAD Start of enrollment: 2015 Oct 05
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Guideline-directed medical therapy implementation during hospitalization for cardiogenic shock.
Matthew G Dimond, Carolyn M Rosner, Seiyon Ben Lee, Unique Shakoor, Taraneh Samadani
ESC Heart Failure. 2025-02-01
1 citations
Advanced Imaging Assessment of the Impact of Tricuspid Regurgitation on Cardiac Remodeling: The TRILUMINATE Pivotal Imaging Substudy.
João L Cavalcante, Markus Scherer, Miho Fukui, Stamatios Lerakis, Serge Harb
Journal of the American College of Cardiology. 2025-01-28
Review of the Decision-Making Approach to The Treatment of Young and Low-Risk Patients with Aortic Stenosis.
Tanush Gupta, S Chris Malaisrie, Wayne Batchelor, Konstantinos Dean Boudoulas, Laura Davidson
The Journal of Thoracic and Cardiovascular Surgery. 2025-01-09

Journal Articles

Coronary Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary Angiography
Somjot Brar, Hitinder S Gurm, Barry Bertolet, Anand Prasad, Dominick J Angiolillo, Roxana Mehran, George Dangas, Wayne Batchelor, Gregg W Stone, ScienceDirect

Books/Book Chapters

The Practice and Principles of Extra-Corporeal Membrane Oxygenation (ECMO)
Chapter: Left Ventricular Unloading in Peripheral Veno-Arterial Extracoporeal Membrane Oxygenation.
Truesdell, Chris King, Behnam Tehrani, Wayne Batchelor, Dan Tang and Ramesh SinghEditors: Michael Firstenberg.Nova Science2021
Cardiac Catheterization, Angiography, and Intervention
Chapter: Percutaneous Therapies for Aortic and Pulmonary Valvular Heart Disease. 's Cardiac Catheterization, Angiography, and Intervention
Damluji,A, Batchelor, WB and Resar, JEditors: Grossman & Baim.Lippincott, Williams and Wilkins, New YorkEdition 9th,2020
Interventional Cardiovascular Medicine
Chapter: Perfusion Balloon Catheter
Batchelor WB, Sketch MH, Stack RS. Perfusion Balloon Catheter. G. Roubin, W O’Neill, and R. StackEditors: G. Roubin, W O’Neill, and R. Stack.Churchill LivingstoneEdition 2nd,2001
Vascular Remodeling and Restenosis
Chapter: Influence of Angioplasty on Matrix Signaling and Metabolism.
Strauss BH, Batchelor WB, Robinson REditors: A. Lafont and E. Topol.Kluwer Academic Publishers1996
Join now to see all

Lectures

The Cardiology Workforce: Current Status and Future Needs
CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/27/2019
Aortic Valve Interventions: Clinical Dilemmas
2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019

Authored Content

Featured Science and Key Takeaways from TCT 2020 (Part 1)October 2020

Press Mentions

The Pulse of ACC | New Guidance: Diagnosing and Managing Myocarditis; In Memoriam: Chartles E. Mullins, MD, FACC; MoreJanuary 6th, 2025
Medtronic Using AI to Identify More TAVR Patients in NeedNovember 20th, 2024
Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVINovember 6th, 2024
Join now to see all